latest news

latest news

We’ll show you what’s new with us here, offer you interesting media outlets that relate to our work, and you can find our press releases here.

Jaromír Zahrádka On SEznam zprávy agenda podcast

Dec 12, 2021

Check out the new episode of the Agenda podcast on Seznam Zprávy. Jaromír Zahrádka, CEO of i&i Bio, talked about our investments this year, investing in Life Sciences and how to find a champion. The video is in Czech language.

i&i Biotech fund Invests $1.5 Million in Sampling Human to Support the Development of Engineered Cells for Single Cell Analysis

Apr 12, 2022

This year's third i&i Bio investment goes to Sampling Human, an early stage, Life Sciences technology company that has developed a diagnostic platform that harnesses genetically engineered cells to analyze other cells in their environment.

i&i Bio's investment of $2 million goes to Dracen Pharmaceuticals, company developing cancer-fighting drugs

Mar 7, 2022

i&i Bio has announced investment of USD 2 million in Dracen Pharmaceuticals. This company is completing the first phase of clinical testing of DRP-104 (sirpiglenastat), which has the potential to significantly help the treatment of cancer. 

i&i Biotech Fund invests €1 million in Celeris Therapeutics, company using AI to develop drugs 

Feb 24, 2022

i&i Bio has announced an investment of EUR 1 million in CelerisTx, an early-stage drug discovery company using artificial intelligence to predict biomolecular interactions and generate new chemical entities. CelerisTx exploits its proprietary platform to develop new drugs in oncology and neurology. 

Jaromír Zahrádka On the Life Science Get2Gether podcast

Dec 12, 2021

In mid-December, Christian Soschner invited our CEO Jaromír Zahrádka to his podcast, which he regularly broadcasts on Life Science Get2Gether (LS G2G).

i&i Bio, the newly established investment fund

Sep 23, 2021

It is our pleasure to announce the start of operations of i&i Biotech Fund (i&i Bio) in September 2021.